Deepinder Goyal and Navil Noronha: a study in contrasting exits
And what that says about how far Eternal can push its norm-defying acts
The Ken Podcast
In a country where the cost of healthcare is through the roof, and regulations around IV drips are still in the grey, this treatment is just as controversial as it is aspirational
IV drip therapy has gone from being a fad among celebrities like the Kardashians, to becoming the wellness treatment for the uber rich. There is a growing consumer interest in quick, customisable wellness solutions and plush clinics across the country are cashing in on it. Whether you are looking to treat a hangover, get glowing skin, lose weight or simply optimise your overall well being – there is an IV infusion for you.
The catch, of course, is that these treatments can cost anywhere from Rs 2,500 to Rs 80,000 per session. But the exorbitant prices of these treatments has hardly been a deterrant for its target audience. In fact, if anything, it’s only shot up to fame.
The Ken reporter DVLS Pranathi spoke to multiple cosmetic clinics – from Kaya, to others like Reviv, Elixir Wellness and Kosmoderma. All of them see IV treatment as their key to tapping into India’s steadily growing health and fitness industry. In fact, today, some of these clinics are doling out thousands of IV drips every month.
But in a country where the cost of healthcare is through the roof, and regulations around IV drips are still in the grey, this treatment is just as controversial as it is aspirational.
*This episode was first published on January 2, 2025
Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.
And what that says about how far Eternal can push its norm-defying acts
The Walmart-backed company commands nearly half of India’s digital-payments landscape. But its financials trail its smaller, listed rival
As the logistics firm plans to pour IPO money into new warehouses and long leases, incumbents are squeezing returns from assets they locked in when land was cheaper, and rents were lower
The Ken has learnt that the Centre is holding deeper discussions on allowing private schools to run as for-profit entities to encourage transparency and long-term steady growth
A complex system with feedback loops that pulls us towards a future we imagine possible
Private labels meet brand ambition
So far, only Wechat seems to have cracked the code to creating an apps-within-an-app ecosystem. Can AI take it to the rest of the world?
The IT services firm is seeking a secondary listing to match the valuation of its Indian rivals. But logistical and regulatory challenges lie in the way
The co-founder on how Darwinbox grew quietly before it grew big
In this episode, we unpack the rise of what we are calling the “fitness warrior”. This is a new professional archetype where work follows the same logic as sport: optimise, train, perform.
As India’s data law kicks in, WhatsApp outreach is getting regulated, and a new compliance market is emerging fast
The IT services firm is seeking a secondary listing to match the valuation of its Indian rivals. But logistical and regulatory challenges lie in the way
The Sequoia-backed cross-border remittance startup Aspora wants to win over 15 million NRIs at all costs, and it has to decide which cost it wants to bear—regulatory or cross-border realities
The Supreme Court’s recent guidelines and a state’s AI mandate hint at a fragmented overhaul—one testing whether tech can cut through decades of procedural drag
Here are the ones—whether it’s The Nutgraf, Long and Short, or Trade Tricks—that you didn’t expect
Here are the stories that our subscribers read and shared the most in 2025
Here are some of the episodes—across our six different podcasts—that listeners loved
Do you know anyone else who would like to listen this podcast?
Share this episode with them.